MGFLX | RPEBX | MGFLX / RPEBX | |
Total Expense Ratio | 1.23 | 1.21 | 102% |
Annual Report Gross Expense Ratio | 1.23 | 1.21 | 102% |
Fund Existence | 21 years | 11 years | - |
Gain YTD | 9.100 | 15.057 | 60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 164M | 159B | 0% |
Annual Yield % from dividends | 0.00 | 0.12 | - |
Returns for 1 year | -3.69 | 13.00 | -28% |
Returns for 3 years | -21.81 | 32.98 | -66% |
Returns for 5 years | -29.19 | 35.37 | -83% |
Returns for 10 years | -30.95 | 80.78 | -38% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTDZX | 138.66 | 1.68 | +1.23% |
Franklin Biotechnology Discovery Adv | |||
STCIX | 9.82 | -0.02 | -0.20% |
Virtus Silvant Large-Cap Growth Stk A | |||
CDOZX | 40.23 | -0.08 | -0.20% |
Columbia Dividend Opportunity Inst | |||
LCEYX | 19.36 | -0.09 | -0.46% |
Invesco Diversified Dividend Y | |||
GCSVX | 9.75 | -0.06 | -0.61% |
Geneva SMID Cap Growth Institutional |